Buparlisib hydrochloride
CAS: 1312445-63-8
Ref. 3D-FB103659
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
Buparlisib hydrochloride
Description:
Buparlisib hydrochloride is an experimental drug that inhibits the function of a protein called phosphoinositide 3-kinase (PI3K), which is involved in cell signaling pathways. The PI3K pathway plays a role in cancer development and progression, including tumor growth, invasiveness, and metastasis. Buparlisib hydrochloride is undergoing clinical trials for the treatment of cancers such as breast cancer and lung cancer. It has been found to have antitumor activity in vivo by inhibiting tumor tissue formation and inhibiting the growth of tumors that are resistant to hormone therapy.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
446.85 g/mol
Formula:
C18H21F3N6O2•HCl
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
